Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Sanara MedTech (SMTI) Depreciation & Amortization - Total (2018 - 2025)

Sanara MedTech's Depreciation & Amortization - Total history spans 8 years, with the latest figure at $42406.0 for Q4 2025.

  • For Q4 2025, Depreciation & Amortization - Total rose 120.69% year-over-year to $42406.0; the TTM value through Dec 2025 reached $175571.0, down 8.05%, while the annual FY2025 figure was $175571.0, 8.05% down from the prior year.
  • Depreciation & Amortization - Total reached $42406.0 in Q4 2025 per SMTI's latest filing, up from $41557.0 in the prior quarter.
  • In the past five years, Depreciation & Amortization - Total ranged from a high of $133301.0 in Q2 2024 to a low of -$204930.0 in Q4 2024.
  • Average Depreciation & Amortization - Total over 5 years is $72549.0, with a median of $97353.5 recorded in 2021.
  • Peak YoY movement for Depreciation & Amortization - Total: skyrocketed 478.76% in 2022, then crashed 266.1% in 2024.
  • A 5-year view of Depreciation & Amortization - Total shows it stood at $93123.0 in 2021, then rose by 15.02% to $107114.0 in 2022, then increased by 15.18% to $123376.0 in 2023, then plummeted by 266.1% to -$204930.0 in 2024, then surged by 120.69% to $42406.0 in 2025.
  • Per Business Quant, the three most recent readings for SMTI's Depreciation & Amortization - Total are $42406.0 (Q4 2025), $41557.0 (Q3 2025), and $45350.0 (Q2 2025).